A Lupinoside prevented fatty acid induced inhibition of insulin sensitivity in 3T3 L1 adipocytes

被引:14
作者
Dey, Debleena
Pal, Bikash C.
Biswas, Tanushree
Roy, Sib Sankar
Bandyopadhyay, Arun
Mandal, Swapan Kumar
Giri, Bir Bhanu
Bhattacharya, Samir [1 ]
机构
[1] Visva Bharati Univ, Cellular & Mol Endocrinol Lab, Dept Zool, Sch Life Sci, Santini Ketan 731235, W Bengal, India
[2] Indian Inst Chem Biol, Kolkata 700032, W Bengal, India
[3] Purulia Sainik Sch, Purulia, W Bengal, India
关键词
diabetes type 2; insulin signal; free fatty acids; glut; 4; translocation; insulin resistance; lupinoside;
D O I
10.1007/s11010-006-9378-1
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The decrease in insulin sensitivity to target tissues or insulin resistance leads to type 2 diabetes mellitus, an insidious disease threatening global health. Numerous evidences made free fatty acids (FFAs) responsible for insulin resistance and type 2 diabetes. We demonstrate here that the damage of insulin acitivity by a free fatty acid, palmitate could be prevented by a lupinoside. An incubation of 3T3 L1 adipocytes with a FFA i.e. palmitate inhibited insulin stimulated uptake of H-3-2 deoxyglucose (2 DOG) significantly. Addition of a lupinoside purified from Pueraria tuberosa, lupinoside PA(4) (LPA(4)) strongly prevented this inhibition. We then examined insulin signaling pathway where palmitate significantly inhibited insulin stimulated phosphorylation of Insulin receptor tyrosine kinase, IRS 1and PI3 kinase, PDK1 and Akt/PKB. LPA(4) rescued this inhibition of signaling molecule by palmitate. Insulin mediated translocation of Glut4, the glucose transporter in insulin target cells, was effectively blocked by palmitate while, LPA(4) waived this block. Administration of LPA(4) to nutritionally induced diabetic rats significantly reduced the increase in plasma glucose. All these indicate LPA(4) to be a potentially therapeutic agent for insulin resistance and type 2 diabetes.
引用
收藏
页码:149 / 157
页数:9
相关论文
共 32 条
[1]  
Arao T, 1997, CHEM PHARM BULL, V45, P362
[2]   Insulin resistance in type 2 diabetes - Role of the adipokines [J].
Arner, P .
CURRENT MOLECULAR MEDICINE, 2005, 5 (03) :333-339
[3]   Activation of protein kinase C-ζ by insulin and phosphatidylinositol-3,4,5-(PO4)3 is defective in muscle in type 2 diabetes and impaired glucose tolerance -: Amelioration by rosiglitazone and exercise [J].
Beeson, M ;
Sajan, MP ;
Dizon, M ;
Grebenev, D ;
Gomez-Daspet, J ;
Miura, A ;
Kanoh, Y ;
Powe, J ;
Bandyopadhyay, G ;
Standaert, ML ;
Farese, RV .
DIABETES, 2003, 52 (08) :1926-1934
[4]   MECHANISMS OF FATTY ACID-INDUCED INHIBITION OF GLUCOSE-UPTAKE [J].
BODEN, G ;
CHEN, XH ;
RUIZ, J ;
WHITE, JV ;
ROSSETTI, L .
JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (06) :2438-2446
[5]   Role of fatty acids in the pathogenesis of insulin resistance and NIDDM [J].
Boden, G .
DIABETES, 1997, 46 (01) :3-10
[6]   A role for ceramide, but not diacylglycerol, in the antagonism of insulin signal transduction by saturated fatty acids [J].
Chavez, JA ;
Knotts, TA ;
Wang, LP ;
Li, GB ;
Dobrowsky, RT ;
Florant, GL ;
Summers, SA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (12) :10297-10303
[7]   Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity [J].
Dresner, A ;
Laurent, D ;
Marcucci, M ;
Griffin, ME ;
Dufour, S ;
Cline, GW ;
Slezak, LA ;
Andersen, DK ;
Hundal, RS ;
Rothman, DL ;
Petersen, KF ;
Shulman, GI .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) :253-259
[8]   Characterization of free and glyceride-esterified long chain fatty acids in different skeletal muscle types of the rat [J].
Górski, J ;
Nawrocki, A ;
Murthy, M .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 1998, 178 (1-2) :113-118
[9]   Free fatty acid-induced insulin resistance is associated with activation of protein kinase C θ and alterations in the insulin signaling cascade [J].
Griffin, ME ;
Marcucci, MJ ;
Cline, GW ;
Bell, K ;
Barucci, N ;
Lee, D ;
Goodyear, LJ ;
Kraegen, EW ;
White, MF ;
Shulman, GI .
DIABETES, 1999, 48 (06) :1270-1274
[10]   A futile metabolic cycle activated in adipocytes by antidiabetic agents [J].
Guan, HP ;
Li, Y ;
Jensen, MV ;
Newgard, CB ;
Steppan, CM ;
Lazar, MA .
NATURE MEDICINE, 2002, 8 (10) :1122-1128